Vivimed Labs.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE526G01021
  • NSEID: VIVIMEDLAB
  • BSEID: 532660
INR
5.53
-0.29 (-4.98%)
BSENSE

Mar 27

BSE+NSE Vol: 2.25 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Dec'25
Sep'25
Dec'24
Jun'23
Mar'23
Dec'22
Sep'22
Net Sales
15.99
20.61
36.51
35.35
37.03
55.74
44.22
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
15.99
20.61
36.51
35.35
37.03
55.74
44.22
Raw Material Cost
8.93
5.30
14.71
17.47
22.71
35.89
24.08
Purchase of Finished goods
0.00
0.00
0.00
0.78
0.06
0.74
0.00
(Increase) / Decrease In Stocks
-1.03
3.82
4.97
-0.16
159.25
1.45
-0.28
Employee Cost
3.70
5.60
7.29
7.63
8.82
9.47
7.71
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.01
0.00
0.00
0.01
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
15.31
6.85
8.47
9.96
10.49
13.31
22.03
Total Expenditure (Excl Depreciation)
26.91
21.57
35.45
35.68
201.33
60.87
53.53
Operating Profit (PBDIT) excl Other Income
-10.92
-0.96
1.06
-0.33
-164.30
-5.13
-9.31
Other Income
0.00
0.21
0.07
0.11
0.68
0.05
0.15
Operating Profit (PBDIT)
-10.92
-0.75
1.13
-0.22
-163.62
-5.08
-9.16
Interest
1.00
1.66
0.48
10.66
8.52
9.22
8.85
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
-11.92
-2.41
0.65
-10.88
-172.14
-14.30
-18.01
Depreciation
4.63
4.90
6.62
4.70
95.92
4.02
4.02
Profit Before Tax
-16.55
-7.30
-5.98
-15.58
-268.05
-18.31
-22.03
Tax
0.00
0.00
0.00
0.00
-2.07
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-16.55
-7.30
-5.98
-15.58
-265.99
-18.31
-22.03
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-16.55
-7.30
-5.98
-15.58
-265.99
-18.31
-22.03
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-16.55
-7.30
-5.98
-15.58
-265.99
-18.31
-22.03
Equity Capital
16.58
16.58
16.58
16.58
16.58
16.58
16.58
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
-2.0
-0.88
-0.72
-1.88
-32.09
-2.21
-2.66
Diluted Earnings per share
-1.94
-0.85
-0.7
-1.82
-31.14
-0.21
-2.58
Operating Profit Margin (Excl OI)
-68.29%
-4.66%
2.9%
-0.93%
-443.69%
-9.2%
-21.05%
Gross Profit Margin
-74.55%
-11.69%
1.78%
-30.78%
-464.87%
-25.65%
-40.73%
PAT Margin
-103.5%
-35.42%
-16.38%
-44.07%
-718.31%
-32.85%
-49.82%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Markets Mojo
Analysis not available as Data has been published for only 1 period
Compare Quarterly Results Of Vivimed Labs. With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
15.99
8,753.40
-8,737.41
-99.82%
Other Operating Income
0.00
0.00
0.00
Total Operating income
15.99
8,753.40
-8,737.41
-99.82%
Raw Material Cost
8.93
1,825.50
-1,816.57
-99.51%
Purchase of Finished goods
0.00
1,542.10
-1,542.10
-100.00%
(Increase) / Decrease In Stocks
-1.03
-272.30
271.27
99.62%
Employee Cost
3.70
1,588.50
-1,584.80
-99.77%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
15.31
2,182.10
-2,166.79
-99.30%
Total Expenditure (Excl Depreciation)
26.91
6,865.90
-6,838.99
-99.61%
Operating Profit (PBDIT) excl Other Income
-10.92
1,887.50
-1,898.42
-100.58%
Other Income
0.00
268.80
-268.80
-100.00%
Operating Profit (PBDIT)
-10.92
2,156.30
-2,167.22
-100.51%
Interest
1.00
94.40
-93.40
-98.94%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
-11.92
2,061.90
-2,073.82
-100.58%
Depreciation
4.63
521.00
-516.37
-99.11%
Profit Before Tax
-16.55
1,543.20
-1,559.75
-101.07%
Tax
0.00
353.60
-353.60
-100.00%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
-16.55
1,187.30
-1,203.85
-101.39%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
-16.55
1,187.30
-1,203.85
-101.39%
Share in Profit of Associates
0.00
2.30
-2.30
-100.00%
Minority Interest
0.00
-20.30
20.30
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-16.55
1,209.90
-1,226.45
-101.37%
Equity Capital
16.58
83.50
-66.92
-80.14%
Face Value
2.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
-2.00
14.49
-16.49
-113.80%
Diluted Earnings per share
-1.94
14.52
-16.46
-113.36%
Operating Profit Margin (Excl OI)
-68.29%
21.63%
0.00
-89.92%
Gross Profit Margin
-74.55%
23.63%
0.00
-98.18%
PAT Margin
-103.50%
13.63%
0.00
-117.13%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 11.63 Cr
in Dec 2025

Figures in Cr
stock-summary

stock-summary

Quarterly - Standalone Net Profit
Standalone Net Profit -16.57 Cr
in Dec 2025

Figures in Cr
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -11.22 Cr
in Dec 2025

Figures in Cr
Quarterly - Interest
Interest 0.94 Cr
in Dec 2025

Figures in Cr
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -96.47%
in Dec 2025

Figures in %